[
    {
        "MOF Name": "SPIO@COF-Guanidyl",
        "Material Category": "MOF composite",
        "Pore/Structural Features": {
            "Pore Size": "3.2 nm",
            "Structure Type": "Regular mesoporous structure"
        },
        "Topology": "Not Reported",
        "Metal Nodes": [
            "Not Reported"
        ],
        "Ligands": [
            "2,5-divinylterephthalaldehyde",
            "1,3,5-tris(4-aminophenyl)benzene"
        ],
        "Guest Molecules": [
            {
                "Molecule Name": "Phosphopeptides",
                "Molecular Size": "Not Reported",
                "Can Pass Sieving": "Yes",
                "Mechanism": "Size-selection effect allows entry into mesoporous channels, coupled with specific affinity interaction by guanidyl groups for capture and enrichment.",
                "Other Information": {
                    "Test Conditions": "Various samples including β-casein tryptic digest, α-casein tryptic digest, non-fat milk tryptic digest, rat liver lysate tryptic digest, and human saliva; enrichment process incubated at room temperature for 30 min.",
                    "Threshold Pressure": "Not Applicable",
                    "Additional Info": "Considered 'small-sized' relative to proteins, successfully captured and identified, including 63 unique endogenous phosphopeptides from human saliva."
                }
            },
            {
                "Molecule Name": "Large-sized proteins (e.g., β-casein, BSA, IgG)",
                "Molecular Size": "Not Reported",
                "Can Pass Sieving": "No",
                "Mechanism": "Size exclusion, prevented from entering the mesoporous channels due to their larger size.",
                "Other Information": {
                    "Test Conditions": "Mixed with β-casein tryptic digest (e.g., molar ratio of β-casein tryptic digest/IgG/BSA was 1:500:500); room temperature.",
                    "Threshold Pressure": "Not Applicable",
                    "Additional Info": "β-casein (MW = 23,000), BSA (MW = 66,000). No peaks detected after enrichment, indicating effective exclusion."
                }
            },
            {
                "Molecule Name": "Non-phosphopeptides",
                "Molecular Size": "Not Reported",
                "Can Pass Sieving": "No",
                "Mechanism": "Excluded by the specific affinity interactions of guanidyl groups, preventing non-specific binding.",
                "Other Information": {
                    "Test Conditions": "Mixed with phosphopeptides (e.g., molar ratios of β-casein and BSA tryptic digests 1:100, 1:1000); non-fat milk tryptic digest; room temperature.",
                    "Threshold Pressure": "Not Applicable",
                    "Additional Info": "High selectivity achieved by preventing the detection of non-phosphopeptide peaks in the spectrum."
                }
            }
        ],
        "Sieving Mechanism": "Combined molecular sieving based on the regular mesoporous pore aperture and specific chemical affinity (guanidyl groups) for targeted size-selection and exclusion.",
        "Experimental Validation": {
            "Method": "MALDI-TOF mass spectrometry (MS), Elite-LC-MS/MS.",
            "Performance Metrics": "High selectivity (β-casein/BSA = 1:1000), extremely high sensitivity (5 × 10−11 M), excellent size-exclusion effect (β-casein digests/β-casein/BSA = 1:500:500), good reusability (at least 5 cycles). Successfully enriched 63 unique endogenous phosphopeptides from 10 μL human saliva."
        },
        "Other Information": {
            "Additional Info": "Novel guanidyl-functionalized magnetic covalent organic framework (COF) nanosphere; synthesized via sequential post-synthetic modification; possessed superior superparamagnetic responsiveness (~42 emu/g saturation magnetization); primarily designed and used for highly selective capture and enrichment of endogenous phosphopeptides from complex biological samples."
        }
    }
]